Medical Care
Global Meningococcal Infections Vaccine Market Research Report 2025
- Sep 18, 25
- ID: 507676
- Pages: 65
- Figures: 62
- Views: 16
This report aims to provide a comprehensive presentation of the global market for Meningococcal Infections Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningococcal Infections Vaccine.
The Meningococcal Infections Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Meningococcal Infections Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meningococcal Infections Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Sinopharm
CanSino Biologics
Zhi Fei Biological
Segment by Type
Bivalent
Quadrivalent
Segment by Application
Group A Meningococcal Bacterial Infections
Group C Meningococcal Bacterial Infectio
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Meningococcal Infections Vaccine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Meningococcal Infections Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Meningococcal Infections Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meningococcal Infections Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Sinopharm
CanSino Biologics
Zhi Fei Biological
Segment by Type
Bivalent
Quadrivalent
Segment by Application
Group A Meningococcal Bacterial Infections
Group C Meningococcal Bacterial Infectio
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Meningococcal Infections Vaccine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Meningococcal Infections Vaccine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Bivalent
1.2.3 Quadrivalent
1.3 Market by Application
1.3.1 Global Meningococcal Infections Vaccine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Group A Meningococcal Bacterial Infections
1.3.3 Group C Meningococcal Bacterial Infectio
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Meningococcal Infections Vaccine Market Perspective (2020-2031)
2.2 Global Meningococcal Infections Vaccine Growth Trends by Region
2.2.1 Global Meningococcal Infections Vaccine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Meningococcal Infections Vaccine Historic Market Size by Region (2020-2025)
2.2.3 Meningococcal Infections Vaccine Forecasted Market Size by Region (2026-2031)
2.3 Meningococcal Infections Vaccine Market Dynamics
2.3.1 Meningococcal Infections Vaccine Industry Trends
2.3.2 Meningococcal Infections Vaccine Market Drivers
2.3.3 Meningococcal Infections Vaccine Market Challenges
2.3.4 Meningococcal Infections Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Meningococcal Infections Vaccine Players by Revenue
3.1.1 Global Top Meningococcal Infections Vaccine Players by Revenue (2020-2025)
3.1.2 Global Meningococcal Infections Vaccine Revenue Market Share by Players (2020-2025)
3.2 Global Meningococcal Infections Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Meningococcal Infections Vaccine Revenue
3.4 Global Meningococcal Infections Vaccine Market Concentration Ratio
3.4.1 Global Meningococcal Infections Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Meningococcal Infections Vaccine Revenue in 2024
3.5 Global Key Players of Meningococcal Infections Vaccine Head office and Area Served
3.6 Global Key Players of Meningococcal Infections Vaccine, Product and Application
3.7 Global Key Players of Meningococcal Infections Vaccine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Meningococcal Infections Vaccine Breakdown Data by Type
4.1 Global Meningococcal Infections Vaccine Historic Market Size by Type (2020-2025)
4.2 Global Meningococcal Infections Vaccine Forecasted Market Size by Type (2026-2031)
5 Meningococcal Infections Vaccine Breakdown Data by Application
5.1 Global Meningococcal Infections Vaccine Historic Market Size by Application (2020-2025)
5.2 Global Meningococcal Infections Vaccine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Meningococcal Infections Vaccine Market Size (2020-2031)
6.2 North America Meningococcal Infections Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Meningococcal Infections Vaccine Market Size by Country (2020-2025)
6.4 North America Meningococcal Infections Vaccine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Meningococcal Infections Vaccine Market Size (2020-2031)
7.2 Europe Meningococcal Infections Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Meningococcal Infections Vaccine Market Size by Country (2020-2025)
7.4 Europe Meningococcal Infections Vaccine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Meningococcal Infections Vaccine Market Size (2020-2031)
8.2 Asia-Pacific Meningococcal Infections Vaccine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2020-2025)
8.4 Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Meningococcal Infections Vaccine Market Size (2020-2031)
9.2 Latin America Meningococcal Infections Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Meningococcal Infections Vaccine Market Size by Country (2020-2025)
9.4 Latin America Meningococcal Infections Vaccine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Meningococcal Infections Vaccine Market Size (2020-2031)
10.2 Middle East & Africa Meningococcal Infections Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2020-2025)
10.4 Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Meningococcal Infections Vaccine Introduction
11.1.4 Pfizer Revenue in Meningococcal Infections Vaccine Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Sinopharm
11.2.1 Sinopharm Company Details
11.2.2 Sinopharm Business Overview
11.2.3 Sinopharm Meningococcal Infections Vaccine Introduction
11.2.4 Sinopharm Revenue in Meningococcal Infections Vaccine Business (2020-2025)
11.2.5 Sinopharm Recent Development
11.3 CanSino Biologics
11.3.1 CanSino Biologics Company Details
11.3.2 CanSino Biologics Business Overview
11.3.3 CanSino Biologics Meningococcal Infections Vaccine Introduction
11.3.4 CanSino Biologics Revenue in Meningococcal Infections Vaccine Business (2020-2025)
11.3.5 CanSino Biologics Recent Development
11.4 Zhi Fei Biological
11.4.1 Zhi Fei Biological Company Details
11.4.2 Zhi Fei Biological Business Overview
11.4.3 Zhi Fei Biological Meningococcal Infections Vaccine Introduction
11.4.4 Zhi Fei Biological Revenue in Meningococcal Infections Vaccine Business (2020-2025)
11.4.5 Zhi Fei Biological Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Meningococcal Infections Vaccine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Bivalent
1.2.3 Quadrivalent
1.3 Market by Application
1.3.1 Global Meningococcal Infections Vaccine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Group A Meningococcal Bacterial Infections
1.3.3 Group C Meningococcal Bacterial Infectio
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Meningococcal Infections Vaccine Market Perspective (2020-2031)
2.2 Global Meningococcal Infections Vaccine Growth Trends by Region
2.2.1 Global Meningococcal Infections Vaccine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Meningococcal Infections Vaccine Historic Market Size by Region (2020-2025)
2.2.3 Meningococcal Infections Vaccine Forecasted Market Size by Region (2026-2031)
2.3 Meningococcal Infections Vaccine Market Dynamics
2.3.1 Meningococcal Infections Vaccine Industry Trends
2.3.2 Meningococcal Infections Vaccine Market Drivers
2.3.3 Meningococcal Infections Vaccine Market Challenges
2.3.4 Meningococcal Infections Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Meningococcal Infections Vaccine Players by Revenue
3.1.1 Global Top Meningococcal Infections Vaccine Players by Revenue (2020-2025)
3.1.2 Global Meningococcal Infections Vaccine Revenue Market Share by Players (2020-2025)
3.2 Global Meningococcal Infections Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Meningococcal Infections Vaccine Revenue
3.4 Global Meningococcal Infections Vaccine Market Concentration Ratio
3.4.1 Global Meningococcal Infections Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Meningococcal Infections Vaccine Revenue in 2024
3.5 Global Key Players of Meningococcal Infections Vaccine Head office and Area Served
3.6 Global Key Players of Meningococcal Infections Vaccine, Product and Application
3.7 Global Key Players of Meningococcal Infections Vaccine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Meningococcal Infections Vaccine Breakdown Data by Type
4.1 Global Meningococcal Infections Vaccine Historic Market Size by Type (2020-2025)
4.2 Global Meningococcal Infections Vaccine Forecasted Market Size by Type (2026-2031)
5 Meningococcal Infections Vaccine Breakdown Data by Application
5.1 Global Meningococcal Infections Vaccine Historic Market Size by Application (2020-2025)
5.2 Global Meningococcal Infections Vaccine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Meningococcal Infections Vaccine Market Size (2020-2031)
6.2 North America Meningococcal Infections Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Meningococcal Infections Vaccine Market Size by Country (2020-2025)
6.4 North America Meningococcal Infections Vaccine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Meningococcal Infections Vaccine Market Size (2020-2031)
7.2 Europe Meningococcal Infections Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Meningococcal Infections Vaccine Market Size by Country (2020-2025)
7.4 Europe Meningococcal Infections Vaccine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Meningococcal Infections Vaccine Market Size (2020-2031)
8.2 Asia-Pacific Meningococcal Infections Vaccine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2020-2025)
8.4 Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Meningococcal Infections Vaccine Market Size (2020-2031)
9.2 Latin America Meningococcal Infections Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Meningococcal Infections Vaccine Market Size by Country (2020-2025)
9.4 Latin America Meningococcal Infections Vaccine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Meningococcal Infections Vaccine Market Size (2020-2031)
10.2 Middle East & Africa Meningococcal Infections Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2020-2025)
10.4 Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Meningococcal Infections Vaccine Introduction
11.1.4 Pfizer Revenue in Meningococcal Infections Vaccine Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Sinopharm
11.2.1 Sinopharm Company Details
11.2.2 Sinopharm Business Overview
11.2.3 Sinopharm Meningococcal Infections Vaccine Introduction
11.2.4 Sinopharm Revenue in Meningococcal Infections Vaccine Business (2020-2025)
11.2.5 Sinopharm Recent Development
11.3 CanSino Biologics
11.3.1 CanSino Biologics Company Details
11.3.2 CanSino Biologics Business Overview
11.3.3 CanSino Biologics Meningococcal Infections Vaccine Introduction
11.3.4 CanSino Biologics Revenue in Meningococcal Infections Vaccine Business (2020-2025)
11.3.5 CanSino Biologics Recent Development
11.4 Zhi Fei Biological
11.4.1 Zhi Fei Biological Company Details
11.4.2 Zhi Fei Biological Business Overview
11.4.3 Zhi Fei Biological Meningococcal Infections Vaccine Introduction
11.4.4 Zhi Fei Biological Revenue in Meningococcal Infections Vaccine Business (2020-2025)
11.4.5 Zhi Fei Biological Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Meningococcal Infections Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Bivalent
Table 3. Key Players of Quadrivalent
Table 4. Global Meningococcal Infections Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Meningococcal Infections Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Meningococcal Infections Vaccine Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Meningococcal Infections Vaccine Market Share by Region (2020-2025)
Table 8. Global Meningococcal Infections Vaccine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Meningococcal Infections Vaccine Market Share by Region (2026-2031)
Table 10. Meningococcal Infections Vaccine Market Trends
Table 11. Meningococcal Infections Vaccine Market Drivers
Table 12. Meningococcal Infections Vaccine Market Challenges
Table 13. Meningococcal Infections Vaccine Market Restraints
Table 14. Global Meningococcal Infections Vaccine Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Meningococcal Infections Vaccine Market Share by Players (2020-2025)
Table 16. Global Top Meningococcal Infections Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Infections Vaccine as of 2024)
Table 17. Ranking of Global Top Meningococcal Infections Vaccine Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Meningococcal Infections Vaccine Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Meningococcal Infections Vaccine, Headquarters and Area Served
Table 20. Global Key Players of Meningococcal Infections Vaccine, Product and Application
Table 21. Global Key Players of Meningococcal Infections Vaccine, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Meningococcal Infections Vaccine Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Meningococcal Infections Vaccine Revenue Market Share by Type (2020-2025)
Table 25. Global Meningococcal Infections Vaccine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Meningococcal Infections Vaccine Revenue Market Share by Type (2026-2031)
Table 27. Global Meningococcal Infections Vaccine Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Meningococcal Infections Vaccine Revenue Market Share by Application (2020-2025)
Table 29. Global Meningococcal Infections Vaccine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Meningococcal Infections Vaccine Revenue Market Share by Application (2026-2031)
Table 31. North America Meningococcal Infections Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Meningococcal Infections Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Meningococcal Infections Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Meningococcal Infections Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Meningococcal Infections Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Meningococcal Infections Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Meningococcal Infections Vaccine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Meningococcal Infections Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Meningococcal Infections Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Meningococcal Infections Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Meningococcal Infections Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 46. Pfizer Company Details
Table 47. Pfizer Business Overview
Table 48. Pfizer Meningococcal Infections Vaccine Product
Table 49. Pfizer Revenue in Meningococcal Infections Vaccine Business (2020-2025) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Sinopharm Company Details
Table 52. Sinopharm Business Overview
Table 53. Sinopharm Meningococcal Infections Vaccine Product
Table 54. Sinopharm Revenue in Meningococcal Infections Vaccine Business (2020-2025) & (US$ Million)
Table 55. Sinopharm Recent Development
Table 56. CanSino Biologics Company Details
Table 57. CanSino Biologics Business Overview
Table 58. CanSino Biologics Meningococcal Infections Vaccine Product
Table 59. CanSino Biologics Revenue in Meningococcal Infections Vaccine Business (2020-2025) & (US$ Million)
Table 60. CanSino Biologics Recent Development
Table 61. Zhi Fei Biological Company Details
Table 62. Zhi Fei Biological Business Overview
Table 63. Zhi Fei Biological Meningococcal Infections Vaccine Product
Table 64. Zhi Fei Biological Revenue in Meningococcal Infections Vaccine Business (2020-2025) & (US$ Million)
Table 65. Zhi Fei Biological Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
Table 69. Authors List of This Report
List of Figures
Figure 1. Meningococcal Infections Vaccine Picture
Figure 2. Global Meningococcal Infections Vaccine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Meningococcal Infections Vaccine Market Share by Type: 2024 VS 2031
Figure 4. Bivalent Features
Figure 5. Quadrivalent Features
Figure 6. Global Meningococcal Infections Vaccine Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Meningococcal Infections Vaccine Market Share by Application: 2024 VS 2031
Figure 8. Group A Meningococcal Bacterial Infections Case Studies
Figure 9. Group C Meningococcal Bacterial Infectio Case Studies
Figure 10. Meningococcal Infections Vaccine Report Years Considered
Figure 11. Global Meningococcal Infections Vaccine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Meningococcal Infections Vaccine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Meningococcal Infections Vaccine Market Share by Region: 2024 VS 2031
Figure 14. Global Meningococcal Infections Vaccine Market Share by Players in 2024
Figure 15. Global Top Meningococcal Infections Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Infections Vaccine as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Meningococcal Infections Vaccine Revenue in 2024
Figure 17. North America Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Meningococcal Infections Vaccine Market Share by Country (2020-2031)
Figure 19. United States Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Meningococcal Infections Vaccine Market Share by Country (2020-2031)
Figure 23. Germany Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Meningococcal Infections Vaccine Market Share by Region (2020-2031)
Figure 31. China Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Meningococcal Infections Vaccine Market Share by Country (2020-2031)
Figure 39. Mexico Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Meningococcal Infections Vaccine Market Share by Country (2020-2031)
Figure 43. Turkey Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Pfizer Revenue Growth Rate in Meningococcal Infections Vaccine Business (2020-2025)
Figure 47. Sinopharm Revenue Growth Rate in Meningococcal Infections Vaccine Business (2020-2025)
Figure 48. CanSino Biologics Revenue Growth Rate in Meningococcal Infections Vaccine Business (2020-2025)
Figure 49. Zhi Fei Biological Revenue Growth Rate in Meningococcal Infections Vaccine Business (2020-2025)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Table 1. Global Meningococcal Infections Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Bivalent
Table 3. Key Players of Quadrivalent
Table 4. Global Meningococcal Infections Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Meningococcal Infections Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Meningococcal Infections Vaccine Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Meningococcal Infections Vaccine Market Share by Region (2020-2025)
Table 8. Global Meningococcal Infections Vaccine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Meningococcal Infections Vaccine Market Share by Region (2026-2031)
Table 10. Meningococcal Infections Vaccine Market Trends
Table 11. Meningococcal Infections Vaccine Market Drivers
Table 12. Meningococcal Infections Vaccine Market Challenges
Table 13. Meningococcal Infections Vaccine Market Restraints
Table 14. Global Meningococcal Infections Vaccine Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Meningococcal Infections Vaccine Market Share by Players (2020-2025)
Table 16. Global Top Meningococcal Infections Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Infections Vaccine as of 2024)
Table 17. Ranking of Global Top Meningococcal Infections Vaccine Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Meningococcal Infections Vaccine Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Meningococcal Infections Vaccine, Headquarters and Area Served
Table 20. Global Key Players of Meningococcal Infections Vaccine, Product and Application
Table 21. Global Key Players of Meningococcal Infections Vaccine, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Meningococcal Infections Vaccine Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Meningococcal Infections Vaccine Revenue Market Share by Type (2020-2025)
Table 25. Global Meningococcal Infections Vaccine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Meningococcal Infections Vaccine Revenue Market Share by Type (2026-2031)
Table 27. Global Meningococcal Infections Vaccine Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Meningococcal Infections Vaccine Revenue Market Share by Application (2020-2025)
Table 29. Global Meningococcal Infections Vaccine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Meningococcal Infections Vaccine Revenue Market Share by Application (2026-2031)
Table 31. North America Meningococcal Infections Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Meningococcal Infections Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Meningococcal Infections Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Meningococcal Infections Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Meningococcal Infections Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Meningococcal Infections Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Meningococcal Infections Vaccine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Meningococcal Infections Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Meningococcal Infections Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Meningococcal Infections Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Meningococcal Infections Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 46. Pfizer Company Details
Table 47. Pfizer Business Overview
Table 48. Pfizer Meningococcal Infections Vaccine Product
Table 49. Pfizer Revenue in Meningococcal Infections Vaccine Business (2020-2025) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Sinopharm Company Details
Table 52. Sinopharm Business Overview
Table 53. Sinopharm Meningococcal Infections Vaccine Product
Table 54. Sinopharm Revenue in Meningococcal Infections Vaccine Business (2020-2025) & (US$ Million)
Table 55. Sinopharm Recent Development
Table 56. CanSino Biologics Company Details
Table 57. CanSino Biologics Business Overview
Table 58. CanSino Biologics Meningococcal Infections Vaccine Product
Table 59. CanSino Biologics Revenue in Meningococcal Infections Vaccine Business (2020-2025) & (US$ Million)
Table 60. CanSino Biologics Recent Development
Table 61. Zhi Fei Biological Company Details
Table 62. Zhi Fei Biological Business Overview
Table 63. Zhi Fei Biological Meningococcal Infections Vaccine Product
Table 64. Zhi Fei Biological Revenue in Meningococcal Infections Vaccine Business (2020-2025) & (US$ Million)
Table 65. Zhi Fei Biological Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
Table 69. Authors List of This Report
List of Figures
Figure 1. Meningococcal Infections Vaccine Picture
Figure 2. Global Meningococcal Infections Vaccine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Meningococcal Infections Vaccine Market Share by Type: 2024 VS 2031
Figure 4. Bivalent Features
Figure 5. Quadrivalent Features
Figure 6. Global Meningococcal Infections Vaccine Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Meningococcal Infections Vaccine Market Share by Application: 2024 VS 2031
Figure 8. Group A Meningococcal Bacterial Infections Case Studies
Figure 9. Group C Meningococcal Bacterial Infectio Case Studies
Figure 10. Meningococcal Infections Vaccine Report Years Considered
Figure 11. Global Meningococcal Infections Vaccine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Meningococcal Infections Vaccine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Meningococcal Infections Vaccine Market Share by Region: 2024 VS 2031
Figure 14. Global Meningococcal Infections Vaccine Market Share by Players in 2024
Figure 15. Global Top Meningococcal Infections Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Infections Vaccine as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Meningococcal Infections Vaccine Revenue in 2024
Figure 17. North America Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Meningococcal Infections Vaccine Market Share by Country (2020-2031)
Figure 19. United States Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Meningococcal Infections Vaccine Market Share by Country (2020-2031)
Figure 23. Germany Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Meningococcal Infections Vaccine Market Share by Region (2020-2031)
Figure 31. China Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Meningococcal Infections Vaccine Market Share by Country (2020-2031)
Figure 39. Mexico Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Meningococcal Infections Vaccine Market Share by Country (2020-2031)
Figure 43. Turkey Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Meningococcal Infections Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Pfizer Revenue Growth Rate in Meningococcal Infections Vaccine Business (2020-2025)
Figure 47. Sinopharm Revenue Growth Rate in Meningococcal Infections Vaccine Business (2020-2025)
Figure 48. CanSino Biologics Revenue Growth Rate in Meningococcal Infections Vaccine Business (2020-2025)
Figure 49. Zhi Fei Biological Revenue Growth Rate in Meningococcal Infections Vaccine Business (2020-2025)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232